Lifeboat Foundation

For me, the concern was just how easy it was to do. A lot of the things we used are out there for free. You can go and download a toxicity dataset from anywhere. If you have somebody who knows how to code in Python and has some machine learning capabilities, then in probably a good weekend of work, they could build something like this generative model driven by toxic datasets. So that was the thing that got us really thinking about putting this paper out there; it was such a low barrier of entry for this type of misuse.

AI could be just as effective in developing biochemical weapons as it is in identifying helpful new drugs, researchers warn.

An advanced bionic arm can be life-changing for a person with an upper limb amputation. But in India, with a population of nearly 1.4 billion and average income of just $2,000 a year, advanced prosthetics are financially out of reach for many amputees.

So the Indian startup Makers Hive developed one that’s not only 90% cheaper, but also more functional.

Advanced prosthetics: A bionic arm contains sensors that press against the skin of the wearer’s residual limb to detect electrical signals from their nerves.

Continue reading “Indian Startup Creates a Bionic Arm That’s 90% Cheaper” »

In a paper published today in Sciences Advances, researchers in the Department of Chemistry and the Department of Physics & Astronomy at the University of California, Irvine revealed new details about a key enzyme that makes DNA sequencing possible. The finding is a leap forward into the era of personalized medicine when doctors will be able to design treatments based on the genomes of individual patients.

None.

In a new article published in eNeuro, fifteen leading scientists of the European Human Brain Project (HBP) outline how a new culture of collaboration and an era of digitalization has transformed neuroscience research over the last decade.

“The way we study the brain has changed fundamentally in recent years,” says first author Katrin Amunts, HBP Scientific Director, Director of the C. and O. Vogt-Institute of Brain Research, Düsseldorf and Director at the Institute of Neuroscience and Medicine at Research Centre Jülich. “In the past, separate communities have often focused on specific aspects of neuroscience, and the problem was always how to link the different worlds, for example, in order to explain a certain cognitive function in terms of the underlying neurobiology.”

Continue reading “The beginning of a new paradigm for understanding the brain” »

Brain research has in recent years indisputably entered a new epoch, driven by substantial methodological advances and digitally enabled data integration and modeling at multiple scales – from molecules to the whole system. Major advances are emerging at the intersection of neuroscience with technology and computing. This new science of the brain integrates high-quality basic research, systematic data integration across multiple scales, a new culture of large-scale collaboration and translation into applications. A systematic approach, as pioneered in Europe’s Human Brain Project (HBP), will be essential in meeting the pressing medical and technological challenges of the coming decade.

WASHINGTON (AP) — Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The request is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.

In a press release, the company said its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical providers to determine the “appropriate use” of a second booster dose of the mRNA vaccine, “including for those at higher risk of COVID-19 due to age or comorbidities.”

A research team from KTH Royal Institute of Technology and Max Planck Institute of Colloids and Interfaces reports to have found the key to controlled fabrication of cerium oxide mesocrystals. The research is a step forward in tuning nanomaterials that can serve a wide range of uses—including solar cells, fuel catalysts and even medicine.

Mesocrystals are nanoparticles with identical size, shape and crystallographic orientation, and they can be used as building blocks to create artificial nanostructures with customized optical, magnetic or electronic properties. In nature, these three-dimensional structures are found in coral, sea urchins and calcite desert rose, for example. Artificially-produced cerium oxide (CeO₂) mesocrystals—or nanoceria—are well-known as catalysts, with antioxidant properties that could be useful in pharmaceutical development.

“To be able to fabricate CeO₂ mesocrystals in a controlled way, one needs to understand the formation mechanism of these materials,” says Inna Soroka, a researcher in applied physical chemistry at KTH. She says the team used radiation chemistry to reveal for the first time the ceria mesocrystal formation mechanism.

Re-engineering clinical trials around participants — katie baca-motes, co-founder, scripps research digital trials center, scripps research.

Katie Baca-Motes, MBA, (https://www.scripps.edu/science-and-medicine/translational-i…aca-motes/) is Senior Director, Strategic Initiatives at the Scripps Research Translational Institute, and Co-Founder of the Scripps Research Digital Trials Center (https://digitaltrials.scripps.edu/).

Continue reading “Katie Baca-Motes — Co-Founder, Scripps Research Digital Trials Ctr — Re-Engineering Clinical Trials” »